School of Women's and Children's Health, Medicine, The University of New South Wales, Randwick, Australia.
Hum Reprod. 2013 Sep;28(9):2554-61. doi: 10.1093/humrep/det270. Epub 2013 Jun 27.
Do mothers following assisted reproduction technology (ART) treatment have increased likelihood of gestational diabetes mellitus (GDM) compared with non-ART mothers after controlling for maternal factors and plurality?
ART mothers had 28% increased likelihood of GDM compared with non-ART mothers.
Advanced maternal age and multiple pregnancies are independently associated with increased likelihood of GDM. Given the average age of mothers having ART treatment is higher than non-ART mothers and the higher multiple pregnancy rate following ART treatment, ART treatment might be expected to be associated with increased risk of GDM.
STUDY DESIGN, SIZE, DURATION: A population retrospective cohort study of 400 392 mothers who gave birth in Australia between 2007 and 2009, using the Australian National Perinatal Data Collection from five states (Australian Capital Territory, Queensland, Tasmania, Victoria and Western Australia) where a code for ART treatment is available.
PARTICIPANTS/MATERIALS, SETTING, METHODS: The study included 13 732 ART mothers and 386 660 non-ART mothers. The prevalence of GDM was compared between ART and non-ART mothers. Logistic regressions were used to assess the association between ART treatment and GDM. Odds ratio (OR), adjusted OR (AOR) and 95% confidence interval (CI) were calculated.
A larger proportion of ART mothers were aged ≥40 years compared with non-ART counterpart (11.7 versus 3.4%, P < 0.01). The prevalence of GDM was 7.6% for ART mothers and 5.0% for non-ART mothers (P < 0.01). Mothers who had twins had higher prevalence of GDM than those who gave births to singletons (8.8 versus 7.5%, P = 0.06 for ART mothers; and 7.3 versus 5.0%, P < 0.01 for non-ART mothers). Overall, ART mothers had a 28% increased likelihood of GDM compared with non-ART mothers (AOR 1.28, 95% CI 1.20-1.37). Of mothers who had singletons, ART mothers had higher odds of GDM than non-ART mothers (AOR 1.26, 95% CI 1.18-1.36). There was no significant difference in the likelihood of GDM among mothers who had twins between ART and non-ART (AOR 1.18, 95% CI 0.94-1.48). For mothers aged <40 years, the younger the maternal age, the higher the odds of GDM for ART singleton mothers compared with non-ART singleton mothers.
LIMITATIONS, REASONS FOR CAUTION: It was not possible to investigate which ART procedure is associated with increased risk of GDM and how the risk could have been minimized. The information on BMI and smoking during pregnancy was not stated for a large proportion of mothers. These limitations may have reduced the validity of the study.
In agreement with other studies, our data suggest that the underlying cause of subfertility and some particular ART procedures might have played an important role in the increased likelihood of GDM. Together with the public education on not delaying motherhood, minimizing multiple pregnancies by applying single embryo transfer may diminish the excess risk of GDM related to ART treatment.
在控制母体因素和多胎妊娠的情况下,接受辅助生殖技术(ART)治疗的母亲与未接受 ART 治疗的母亲相比,患妊娠糖尿病(GDM)的可能性是否更高?
与非 ART 母亲相比,ART 母亲患 GDM 的可能性增加了 28%。
高龄产妇和多胎妊娠与 GDM 发生的可能性增加独立相关。鉴于接受 ART 治疗的母亲的平均年龄高于非 ART 母亲,并且接受 ART 治疗后多胎妊娠的发生率更高,因此可以预期 ART 治疗与 GDM 风险增加相关。
研究设计、规模、持续时间:这是一项在澳大利亚五个州(澳大利亚首都领地、昆士兰州、塔斯马尼亚州、维多利亚州和西澳大利亚州)进行的基于人群的回顾性队列研究,使用澳大利亚国家围产期数据收集,这些州有关于 ART 治疗的代码。共有 400392 名在 2007 年至 2009 年期间在澳大利亚分娩的母亲参与了这项研究,其中包括 13732 名接受 ART 治疗的母亲和 386660 名未接受 ART 治疗的母亲。比较了 ART 母亲和非 ART 母亲的 GDM 患病率。使用逻辑回归评估 ART 治疗与 GDM 之间的关联。计算了比值比(OR)、调整后 OR(AOR)和 95%置信区间(CI)。
与非 ART 母亲相比,接受 ART 治疗的母亲中年龄≥40 岁的比例更大(11.7%比 3.4%,P<0.01)。ART 母亲的 GDM 患病率为 7.6%,而非 ART 母亲的 GDM 患病率为 5.0%(P<0.01)。怀双胞胎的母亲 GDM 患病率高于怀单胎的母亲(ART 母亲为 8.8%比 7.5%,P=0.06;非 ART 母亲为 7.3%比 5.0%,P<0.01)。总体而言,与非 ART 母亲相比,ART 母亲患 GDM 的可能性增加了 28%(AOR 1.28,95%CI 1.20-1.37)。在怀单胎的母亲中,ART 母亲患 GDM 的几率高于非 ART 母亲(AOR 1.26,95%CI 1.18-1.36)。在怀双胞胎的母亲中,ART 母亲和非 ART 母亲的 GDM 患病几率没有显著差异(AOR 1.18,95%CI 0.94-1.48)。对于年龄<40 岁的母亲,年龄越小,ART 单胎母亲患 GDM 的几率越高,而非 ART 单胎母亲的几率越低。
局限性、谨慎的原因:无法研究哪种 ART 程序与 GDM 风险增加相关,以及如何将风险降到最低。很大一部分母亲的 BMI 和孕期吸烟信息没有说明。这些限制可能降低了研究的有效性。
与其他研究一致,我们的数据表明,导致不孕的潜在原因和某些特定的 ART 程序可能在 GDM 发生几率增加中发挥了重要作用。与提倡不要延迟生育的公众教育相结合,通过应用单胚胎移植来减少多胎妊娠,可以降低与 ART 治疗相关的 GDM 过度风险。